Major depressive disorder treatment guidelines in China

J Clin Psychiatry. 2010:71 Suppl E1:e06. doi: 10.4088/JCP.9058se1c.06gry.

Abstract

Depression is a common illness in the Chinese population, but very few people with depression seek treatment or are properly diagnosed and treated when they do visit a medical professional. One potential result of this situation is that suicidality is higher than it might be if more people with depression received appropriate treatment. When patients do receive pharmacotherapy for depression, benzodiazepines and tricyclic antidepressants are overprescribed. The Chinese psychiatric establishment has published a sufficient guideline outlining treatment strategies for depressive disorders, but education for psychiatrists and general practitioners is needed.

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Benzodiazepines / therapeutic use
  • China
  • Cross-Cultural Comparison
  • Cross-Sectional Studies
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / epidemiology
  • Depressive Disorder, Major / psychology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Evidence-Based Medicine*
  • Hospitalization
  • Humans
  • Long-Term Care
  • Practice Guidelines as Topic
  • Secondary Prevention

Substances

  • Antidepressive Agents
  • Benzodiazepines